Insulin receptor substrate-1 suppresses transforming growth factor-β1-mediated epithelial-mesenchymal transition

Cancer Research

Volumn 69, Issue 18, 2009, Pages 7180-7187

  Shi, Jian ^a   Wang, Dong Mei ^a   Wang, Chun Mei ^b   Hu, Ying ^a   Liu, Ai Hua ^b   Zhang, Yong Lian ^b   Sun, Bing ^a   Song, Jian Guo ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b Chinese Academy of Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN TYROSINE PHOSPHATASE; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE; UVOMORULIN; VANADATE SODIUM;

ARTICLE; CELL MIGRATION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; LUNG CARCINOMA; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; TISSUE MICROARRAY; TRANSCRIPTION INITIATION;

CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL CELLS; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; LUNG NEOPLASMS; MESODERM; PHOSPHORYLATION; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 70349750200     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4470     Document Type: Article

References (33)

1. Prindull G, Zipori D. Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm. Blood 2004;103:2892-2899 (Pubitemid 38451657)
2. Hugo H, Ackland ML, Blick T, et al. Epithelialmesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007;213:374-383 (Pubitemid 47509716)
3. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006;172:973-981 (Pubitemid 46956836)
4. Voulgari A, Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta. Epub ahead of print 2009 Mar 21.
5. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006;7:131-142
6. Tse JC, Kalluri R. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 2007;101:816-829 (Pubitemid 47040864)
7. Moustakas A, Heldin CH. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 2007;98:1512-1520 (Pubitemid 47308444)
8. Zavadil J, Böttinger EP. TGF-β and epithelial-to-mesenchymal transitions. Oncogene 2005;24:5764-5774
9. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007;7:415-428
10. Yang YN, Pan XC, Lei WW, Wang J, Song JG. Transforming growth factor-β1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism. Oncogene 2006;25:7235-7244 (Pubitemid 44809089)
11. Yang YN, Pan XC, Lei WW, et al. Regulation of transforming growth factor-b1-Induced apoptosis and epithelial-to-mesenchymal transition by protein kinase A and signal transducers and activators of transcription 3. Cancer Res 2006;66:8617-8624
12. White MF. Insulin signaling in health and disease. Science 2003;302:1710-1711
13. Gual P, Le Marchand-Brustel Y, Tanti JF. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2005;87:99-109. (Pubitemid 40298772)
14. Shi B, Sepp-Lorenzino L, Prisco M, Linsley P, Deangelis T, Baserga R. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 2007;282:32582-32590 (Pubitemid 350159311)
15. Ravikumar S, Perez-Liz G, Del Vale L, Soprano DR, Soprano KJ. Insulin receptor substrate-1 is an important mediator of ovarian cancer cell growth suppression by all-trans retinoic acid. Cancer Res 2007;67:9266-9275 (Pubitemid 47535915)
16. Dromard M, Bompard G, Glondu-Lassis M, Puech C, Chalbos D, Freiss G. The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation. Cancer Res 2007;67:6806-6813
17. Cesarone G, Garofalo C, Abrams MT, et al. RNA-imediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells. J Cell Biochem 2006;98:440-450
18. Schnarr B, Strunz K, Ohsam J, Benner A, Wacker J, Mayer D. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer. Int J Cancer 2000;89:506-513
19. Han CH, Cho JY, Moon JT, et al. Clinical significance of insulin receptor substrate-I down-regulation in nonsmall cell lung cancer. Oncol Rep 2006;16:1205-1210
20. Reiss K, Wang JY, Romano G, et al. IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation. Oncogene 2000;19:2687-2694 (Pubitemid 30326418)
21. Ma Z, Gibson SL, Byrne MA, Zhang J, White MF, Shaw LM. Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis. Mol Cell Biol 2006;26:9338-9351 (Pubitemid 44904428)
22. Gibson SL, Ma Z, Shaw LM. Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis. Cell Cycle 2007;6:631-637 (Pubitemid 46535670)
23. Tanaka S, Wands JR. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor β1-induced apoptosis. Cancer Res 1996;56:3391-3394 (Pubitemid 26251624)
24. Tseng YH, Kriauciunas KM, Kokkotou E, Kahn CR. Differential roles of insulin receptor substrates in brown adipocyte differentiation. Mol Cell Biol 2004;24:1918-1929 (Pubitemid 38248933)
25. Sentinelli F, Filippi E, Cavallo MG, Romeo S, Fanelli M, Baroni MG. The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARγ agonist restores normal cell signaling and differentiation. J Endocrinol 2006;188:271-285 (Pubitemid 43273815)
26. Rubin R, Arzumanyan A, Soliera AR, Ross B, Peruzzi F, Prisco M. Insulin receptor substrate (IRS)-1 regulates murine embryonic stem (mES) cells self-renewal. J Cell Physiol 2007;213:445-453 (Pubitemid 47509726)
27. Martin KA, Merenick BL, Ding M, et al. Rapamycin promotes vascular smooth muscle cell differentiation through IRS-1/PI3-Kinase/Akt2 feedback signaling. J Biol Chem 2007;282:36112-36120
28. Chen HH, Zhao S, Song JG. TGF-β1 suppresses apoptosis via differential regulation of MAP kinases and ceramide production. Cell Death Differ 2003;10:516-527 (Pubitemid 36656641)
29. Zhao S, Du XY, Chen JS, Zhou YC, Song JG. Secretory phospholipase A2 inhibits epidermal growth factor-induced receptor activation. Exp Cell Res 2002;279:354-364 (Pubitemid 35217563)
30. Saad MJ, Folli F, Kahn CR. Insulin and dexamethasone regulate insulin receptors, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in Fao hepatoma cells. Endocrinology 1995;136:1579-1588
31. Turnbow MA, Keller SR, Rice KM, Garner CW. Dexamethasone down-regulation of insulin receptor substrate-1 in 3T3-1 adipocytes. J Biol Chem 1994;269:2516-2520 (Pubitemid 24235744)
32. deVente JE, Carey JO, Bryant WO, Pettit GJ, Ways DK. Transcriptional regulation of insulin receptor substrate 1 by protein kinase C. J Biol Chem 1996;271:32276-32280
33. Dearth RK, Cui X, Kim HJ, Hadsell DL, Lee AV. Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2. Cell Cycle 2007;6:705-713 (Pubitemid 46535683)